Security key
010911105
Alamar Biosciences, Inc. - Common Stock (ALMR)
CUSIP: 010911105
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 24,374,750
- Total 13F value
- $660,377,538
- Share change
- +24,372,719
- SEC-reported price per share
- $27.09
- Number of holders
- 85
- Value change
- +$660,322,518
- Number of buys
- 84
- Shares outstanding
- 70,761,219
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
85
Top holders
10
ALMR full security history
Ownership snapshot
Full 13F holder table
Alamar Biosciences, Inc. SEC filings
Alamar Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 010911105
Recent filing periods:
Ownership snapshot
Top reported holders of ALMR - Alamar Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Qiming Corporate GP VI, Ltd.
Disclosed value leader
Qiming Corporate GP VI, Ltd.
Comparable rows
3/15
Latest evidence
30 Jun 2026
13D/G
3/4/5
Lead comparable stake: 10%
12 rows are not safely comparable across share classes.
13D/G row: Qiming Corporate GP VI, Ltd.
Showing 1-6 of 15 holder rows.
Quick read
Qiming Corporate GP VI, Ltd. leads the comparable SEC ownership view at 10%.
3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Qiming Corporate GP VI, Ltd.'s linked filing trail.
Comparable ownership
Top 3
Qiming Corporate GP VI, Ltd.
10%
SHERPA HEALTHCARE FUND II, L.P.
7.2%
Yuling Luo
6.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Qiming Corporate GP VI, Ltd. |
13D/G
3/4/5
10%+ Owner
|
10%
|
$184,649,552
7,066,573 shares
|
$0 | 30 Jun 2026 |
| SHERPA HEALTHCARE FUND II, L.P. |
13D/G
Daqing Cai
|
7.2%
|
$110,331,653
4,972,134 shares
|
$0 | 16 Apr 2026 |
| Yuling Luo |
13D/G
3/4/5
Chief Executive Officer, Director
|
6.4%
|
$118,335,401
4,528,718 shares
|
$0 | 30 Jun 2026 |
| Qiming GP VIII, LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
—
1,922,329 shares
|
— | 20 Apr 2026 |
| Qiming GP VIII-HC, LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
—
1,922,329 shares
|
— | 20 Apr 2026 |
| Qiming Managing Directors Fund VI, L.P. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
—
1,922,329 shares
|
— | 20 Apr 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
85
Shares
24,374,750
Rows available
85
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
0
Q2 2026 holders
85
Holder diff
85
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend